Evidence map›Paper›PMID 29028184›Full record

ArticleeLife2017

Native KCC2 interactome reveals PACSIN1 as a critical regulator of synaptic inhibition.

Vivek Mahadevan, C Sahara Khademullah, Zahra Dargaei, Jonah Chevrier, Pavel Uvarov, Julian Kwan, Richard D Bagshaw, Tony Pawson, Andrew Emili, Yves De Koninck and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Enhancing KCC2 function reduces interictal activity and prevents seizures in temporal lobe epilepsy.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. VCP controls KCC2 degradation through FAF1 recruitment and accelerates emergence from anesthesia.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Neuronal KActa pharmacologica Sinica · 2024
    Review
  11. Therapeutic potential for KCC2-targeted neurological diseases.The Japanese dental science review · 2023
    Review
  12. Delaying the GABA Shift Indirectly Affects Membrane Properties in the Developing Hippocampus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  13. Article
  14. KFrontiers in cellular neuroscience · 2023
    Article
  15. PACSIN proteins in vivo: Roles in development and physiology.Acta physiologica (Oxford, England) · 2022
    Review
  16. Gephyrin Interacts with the K-Cl Cotransporter KCC2 to Regulate Its Surface Expression and Function in Cortical Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Vivek MahadevanDepartment of Cell and Systems Biology, University of Toronto, Toronto, Canada.ORCID 0000-0002-0805-827X
C Sahara KhademullahDepartment of Cell and Systems Biology, University of Toronto, Toronto, Canada.
Zahra DargaeiDepartment of Cell and Systems Biology, University of Toronto, Toronto, Canada.
Jonah ChevrierDepartment of Cell and Systems Biology, University of Toronto, Toronto, Canada.
Pavel UvarovDepartment of Anatomy, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-8439-6150
Julian KwanDepartment of Molecular Genetics, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Canada.
Richard D BagshawLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.
Tony PawsonLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.
Andrew EmiliDepartment of Molecular Genetics, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Canada.
Yves De KoninckInstitut Universitaire en Santé Mentale de Québec, Québec, Canada.
Victor AnggonoQueensland Brain Institute, Clem Jones Centre for Ageing Dementia Research, The University of Queensland, Brisbane, Australia.ORCID 0000-0002-4062-4884
Matti AiraksinenDepartment of Anatomy, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Melanie A WoodinDepartment of Cell and Systems Biology, University of Toronto, Toronto, Canada.ORCID 0000-0003-2984-8630
University of Toronto · CAMount Sinai Hospital · CAUniversity of Helsinki · FIInstitut Universitaire en Santé Mentale de Québec · CAThe University of Queensland · AU

Funding

CIHR FRN-133431Wellcome Trust
6 · The paper itself

Abstract

KCC2 is a neuron-specific K

Indexed as

Protein Interaction MapsAdaptor Proteins, Signal TransducingAnimalsBrainImmunoprecipitationIntracellular Signaling Peptides and ProteinsK Cl- CotransportersMass SpectrometryMice, Inbred C57BLNeuronsNeuropeptidesPhosphoproteinsProteomicsSymportersSynapsesAdaptor Proteins, Signal TransducingIntracellular Signaling Peptides and ProteinsK Cl- CotransportersNeuropeptidesPacsin1 protein, mousePhosphoproteinsSymporterschlorideGabainteractomeKCC2mouseneurosciencePACSIN1syndapin

Identifiers

PMID29028184
PMCPMC5640428
OpenAlexW2952793599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.